Skip to main content
Journal of Dental Research logoLink to Journal of Dental Research
. 2018 Oct 1;98(2):180–185. doi: 10.1177/0022034518801537

Gene-Gene Interactions among SPRYs for Nonsyndromic Cleft Lip/Palate

R Zhou 1, M Wang 1, W Li 1, S Wang 1, Z Zhou 2, J Li 2, T Wu 1,3,, H Zhu 2, TH Beaty 4
PMCID: PMC6900437  PMID: 30273098

Abstract

Nonsyndromic cleft lip with or without cleft palate (NSCL/P) is a common birth defect with a complex genetic architecture. Gene-gene interactions have been increasingly regarded as contributing to the etiology of NSCL/P. A recent genome-wide association study revealed that a novel single-nucleotide polymorphism at SPRY1 in 4q28.1 showed a significant association with NSCL/P. In the current study, we explored the role of 3 SPRY genes in the etiology of NSCL/P by detecting gene-gene interactions: SPRY1, SPRY2, and SPRY4—with SPRY3 excluded due to its special location on the X chromosome. We selected markers in 3 SPRY genes to test for gene-gene interactions using 1,908 case-parent trios recruited from an international consortium established for a genome-wide association study of nonsyndromic oral clefts. As the trios came from populations with different ancestries, subgroup analyses were conducted among Europeans and Asians. Cordell’s method based on conditional logistic regression models was applied to test for potential gene-gene interactions via the statistical package TRIO in R software. Gene-gene interaction analyses yielded 10 pairs of SNPs in Europeans and 6 pairs in Asians that achieved significance after Bonferroni correction. The significant interactions were confirmed in the 10,000-permutation tests (empirical P = 0.003 for the most significant interaction). The study identified gene-gene interactions among SPRY genes among 1,908 NSCL/P trios, which revealed the importance of potential gene-gene interactions for understanding the genetic architecture of NSCL/P. The evidence of gene-gene interactions in this study also provided clues for future biological studies to further investigate the mechanism of how SPRY genes participate in the development of NSCL/P.

Keywords: genetic association study, cleft palate, congenital abnormalities, birth defects, single-nucleotide polymorphism, case-parent trios

Introduction

Nonsyndromic cleft lip with or without cleft palate (NSCL/P) is a common birth defect around the world, with varied prevalence among geographic regions (Panamonta et al. 2015). American Indians, Japanese, and Chinese have a relatively higher prevalence than do Africans and Europeans (Panamonta et al. 2015). The development of NSCL/P involves various genetic and environmental factors (Leslie and Marazita 2013). To date, genome-wide association studies (GWASs) have identified multiple loci influencing the risk of NSCL/P (Birnbaum et al. 2009; Beaty et al. 2010; Mangold et al. 2010; Ludwig et al. 2012; Sun et al. 2015; Ludwig et al. 2016; Leslie, Carlson, et al. 2016; Leslie, Liu, et al. 2016; Yu et al. 2017; Leslie, Carlson, Shaffer, Butali, et al. 2017). Despite much progress in the exploration of genetic risk factors for NSCL/P, only about 20% of the heritability can be explained by those susceptibility loci identified in the previous studies (Leslie, Carlson, Shaffer, Buxo, et al. 2017). The “missing heritability” can derive from common variants with too small effect sizes to be identified, rare variants not captured in GWASs, gene-gene interactions, gene-environment interactions, and parents-of-origin effects (Eichler et al. 2010). Therefore, testing for gene-gene interactions in the context of GWASs is an important approach to further explore the etiology of NSCL/P (Frazer et al. 2009; Steen 2012). Multiple gene-gene interactions have been identified to contribute to the risk of NSCL/P. For example, Song et al. (2013) identified 3 single-nucleotide polymorphisms (SNPs) (rs2073485, rs2235371, and rs2236909) in IRF6 showing interactions with rs2235373 in PAX9. Liu et al. (2017) reported 9 pairs of SNP-SNP interactions within the region of 16p13.3 potentially important to the susceptibility of NSCL/P. Evidence also supported gene-gene for TGFA-MTHFR and WNT5B-MAFB (Jugessur et al. 2003; Li et al. 2015). However, Beaty et al. (2013) failed to identify any interaction among 8q24, IRF6, ABCA4, MAFB, PAX7, THADA, COL8A1, and DCAF4L2. Although not all studies successfully identified gene-gene interactions among genes of interest, testing for gene-gene interactions was still a practical approach to explore the etiology of NSCL/P.

Sprouty genes contain 4 members—SPRY1, SPRY2, SPRY3, and SPRY4—located on 4 chromosomes. Yu et al. (2017) first reported that an SNP at SPRY1 in 4q28.1 showed a significant association with NSCL/P after Bonferroni correction, with 3,379 NSCL/P cases and 8,593 controls with Chinese ancestry. They further successfully replicated this variant with another 861 trios with Asian ancestry. This study also replicated a previously reported locus, 13q31.1 (SPRY2), in the Chinese population. Several studies further reported signals in SPRY1 and SPRY2 to be associated with NSCL/P among European populations (Ludwig et al. 2012; Jia et al. 2015; de Araujo et al. 2016). Although GWASs have provided some evidence for these loci in the etiology of NSCL/P, the identified associations were primarily located in noncoding regions, and the underlying mechanisms remained unknown. Therefore, exploring gene-gene interactions among SPRY genes was a possible approach to better understand the etiology of NSCL/P.

In the current study, we aimed to explore potential gene-gene interactions among 3 SPRY genes (SPRY1, SPRY2, SPRY4). As SPRY3 locates on the X chromosome, we excluded it for gene-gene interaction analysis. This study used GWAS data of 1,908 case-parent trios who were recruited from an international consortium (Beaty et al. 2010). Considering the genetic heterogeneity among populations with different ancestries, we also analyzed the data stratified by European and Asian populations.

Materials and Methods

The report of this study followed the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) guidelines.

Study Population

A total of 1,908 NSCL/P case-parent trios with European or Asian ancestry were drawn from an international consortium that conducted a GWAS. Details of the sample were introduced by Beaty et al. (2010). Most were with European ancestry (825 trios) or Asian ancestry (1,038 trios). Clinicians examined each case to exclude the syndromic forms of cleft lip with or without cleft palate. The research protocol was reviewed and approved by the Institutional Review Board of each institution participating in this international consortium, including the Johns Hopkins School of Public Health, University of Pittsburgh, Utah State University, University of Iowa, among others. Written informed consent was obtained from each participant. DNA was extracted from whole blood, saliva, or a mouthwash sample for cases and parents.

Genotyping and SNP Selection

DNA samples were genotyped with Illumina Human610-Quad v.1_B Bead Chip at the Center for Inherited Disease Research, Johns Hopkins University. SNPs located in or near gene regions were mapped to genes according to the National Center for Biotechnology Information human genome build 36.1. In the process of quality control, SNPs would be excluded if they met any of the following criteria: 1) missing genotype information >10%, 2) low minor allele frequency (MAF) among founders <0.1, 3) significant deviation of Hardy-Weinberg equilibrium among parents <0.001, and 4) Mendelian error >5%. Quality control was performed for all 1,908 trios by PLINK 1.07 and for European and Asian subgroup analysis, yielding 149 SNPs for all 1,908 trios, 206 SNPs for European trios, and 189 SNPs for Asian trios for analysis. Detailed information of the SNPs is included in Appendix Tables 1 to 3.

Statistical Methods

The Cordell (2002) method was used to detect gene-gene interactions, where 15 “pseudo-controls” were created for each case and a conditional logistic regression model was built to assess the SNP-SNP interaction under the additive model of inheritance. To consider 2-way interactions, the 15 pseudo-controls were generated on the basis of the parents’ genotypes at the 2 loci, where the genotype at the 2 loci for each pseudo-control consisted of 1 of the 2-locus genotypes that was possible but not transmitted to the case. The conditional logistic regression model under the additive model of inheritance (full model) was as follows:

log(pij1pij)=a1x1+d1z1+a2x2+d2z2+iaax1x2+iadx1z2+idaz1x2+iddz1z2,

where xi and zi were dummy variables related to the underlying genotype at locus I; the coefficients a1, d1, a2, and d2 represented additive (ai) and dominance (di) effects at the 2 loci; and iaa, iad, ida, and idd corresponded to the epistatic interaction effects (Cordell 2002). The lack of interactions could be inferred when 4 interaction coefficients equaled zero. Then, the model could be simplified as

log(pij1pij)=a1x1+d1z1+a2x2+d2z2(nullmodel).

Likelihood ratio tests were conducted to compare the full model and null model, providing an overall 4-df test of interaction. The significance levels were set as 2.4 × 10–4 (0.05/206) for the European population and 2.6 × 10–4 (0.05/189) for the Asian population after the Bonferroni correction. The permutation test was also conducted to minimize the possibility of obtaining false-positive results. The disease status of “cases” and “pseudo-controls” was randomly shuffled 10,000 times. The P value for the permutation test was the probability of obtaining a more extreme statistic than the observed data. Cordell’s method and permutation tests were both conducted in the TRIO package (version 3.16.0) in R software (version 3.4.3).

To further check the consistency of genetic risk factors across different ancestries, subgroup analyses were conducted for the European and Asian populations, since these 2 populations together composed nearly 95% of all trios.

Results

A total of 1,908 NSCL/P trios were included in the analysis of gene-gene interactions, with subgroup analyses performed in the European trios and Asian trios. Quality controls of genotyped data for all 1,908 trios excluded 64 SNPs due to a failing Hardy-Weinberg equilibrium test and 46 SNPs due to low MAF, leaving 149 SNPs to be analyzed. In the quality control of subgroup analyses, 39 SNPs and 56 SNPs were filtered due to low MAF in European trios and Asian trios, respectively, leaving 206 SNPs and 189 SNPs for each subgroup.

In the test for gene-gene interactions among 1,908 trios, 1 pair of SNPs achieved significance after Bonferroni correction, rs7697652 (SPRY1) and rs9601485 (SPRY2), with a P value of 3.59 × 10−5. The top 10 pairs of SNPs for gene-gene interactions among 1,908 trios are listed in Table 1.

Table 1.

Top 10 Pairs of Single-Nucleotide Polymorphisms for Gene-Gene Interactions among 1,908 Trios with Nonsyndromic Cleft Lip with or without Cleft Palate.

First Gene Marker 1 MAF1a Second Gene Marker 2 MAF2a P Value Empirical P Valueb
SPRY1 rs7697652 0.280 SPRY2 rs9601485 0.220 3.59E-05c <0.001
SPRY1 rs7697652 0.280 SPRY2 rs7320320 0.206 3.49E-04
SPRY1 rs7697652 0.280 SPRY2 rs4267202 0.280 4.18E-04
SPRY2 rs1478875 0.490 SPRY4 rs4244027 0.433 6.28E-04
SPRY1 rs12505913 0.383 SPRY2 rs2096347 0.247 6.56E-04
SPRY2 rs1010390 0.428 SPRY4 rs4244027 0.433 6.97E-04
SPRY2 rs486467 0.292 SPRY4 rs9800206 0.464 8.51E-04
SPRY1 rs12233855 0.438 SPRY2 rs2759243 0.410 1.02E-03
SPRY1 rs12505913 0.383 SPRY2 rs2876759 0.385 1.08E-03
SPRY1 rs12505913 0.383 SPRY2 rs1984294 0.386 1.10E-03
a

Minor allele frequency.

b

Empirical P values from permutation test were calculated only for single-nucleotide polymorphism pairs remaining significant after Bonferroni correction.

c

Remaining significant after Bonferroni correction.

To check the consistency across different ancestries, subgroup analyses were conducted among European trios and Asian trios. The analyses showed appealing results where another pair of genes, SPRY2-SPRY4, appeared in the stratified analyses based on European and Asian subgroups. Moreover, the pairs of genes involved in gene-gene interactions kept consistent across subgroups—namely, SPRY1-SPRY2 and SPRY2-SPRY4. Among trios of European ancestry, 10 pairs of SNPs reached the corrected significance level, with rs2876761 (SPRY2) and rs11739594 (SPRY4) yielding the most significant signal (P = 4.91 × 10−5). Among them, 4 pairs of SNPs supported the interactions between SPRY2 and SPRY4, as well as 6 pairs of SNPs indicating interactions between SPRY1 and SPRY2. Among the trios of Asian ancestry, 6 pairs of SNPs showed statistically significant interactions after the Bonferroni correction for multiple tests, with rs2478223 (SPRY2) and rs9800206 (SPRY4) yielding the smallest P value, 2.81 × 10−5. The top 10 pairs of SNPs for gene-gene interactions in European and Asian population are listed in Table 2. Permutation tests were also performed to confirm the results. The pairwise gene-gene interactions discovered here remained significant in permutation tests. Empirical P values of permutation tests for those SNP pairs that achieved the corrected significance are also listed in Tables 1 and 2.

Table 2.

Top 10 Pairs of Single-Nucleotide Polymorphisms for Gene-Gene Interactions among Trios with European or Asian Ancestry.

Ancestry: First Gene Marker 1 MAF1a Second Gene Marker 2 MAF2a P Value Empirical P Valueb
European
 SPRY2 rs2876761 0.324 SPRY4 rs11739594 0.331 4.91E-05c <0.001
 SPRY1 rs3860074 0.301 SPRY2 rs11149181 0.217 1.39E-04c <0.001
 SPRY1 rs3860074 0.301 SPRY2 rs12854744 0.216 1.47E-04c <0.001
 SPRY1 rs7677413 0.188 SPRY2 rs7321702 0.489 1.66E-04c <0.001
 SPRY1 rs3860074 0.301 SPRY2 rs11618325 0.212 1.82E-04c <0.001
 SPRY1 rs3860074 0.301 SPRY2 rs1358977 0.217 1.87E-04c <0.001
 SPRY1 rs12233855 0.457 SPRY2 rs9574697 0.212 2.01E-04c <0.001
 SPRY2 rs4344612 0.240 SPRY4 rs4912846 0.257 2.06E-04c <0.001
 SPRY2 rs4344612 0.240 SPRY4 rs11954937 0.287 2.27E-04c <0.001
 SPRY2 rs12867395 0.192 SPRY4 rs4912846 0.257 2.31E-04c <0.001
Asian
 SPRY2 rs2478223 0.238 SPRY4 rs9800206 0.423 2.81E-05c 0.003
 SPRY2 rs2503378 0.241 SPRY4 rs9800206 0.423 3.53E-05c 0.001
 SPRY2 rs2759236 0.424 SPRY4 rs10061008 0.262 1.32E-04c 0.003
 SPRY2 rs2794251 0.425 SPRY4 rs10061008 0.262 1.58E-04c 0.004
 SPRY1 rs4833925 0.164 SPRY2 rs1287530 0.195 2.12E-04c <0.001
 SPRY2 rs2759243 0.429 SPRY4 rs10061008 0.262 2.44E-04c 0.002
 SPRY2 rs7329886 0.456 SPRY4 rs9800206 0.423 3.45E-04
 SPRY2 rs1176270 0.429 SPRY4 rs10061008 0.262 4.46E-04
 SPRY1 rs7697652 0.224 SPRY2 rs9601485 0.206 4.72E-04
 SPRY1 rs7697652 0.224 SPRY2 rs7320320 0.205 5.05E-04
a

Minor allele frequency.

b

Empirical P values from permutation test were calculated only for single-nucleotide polymorphism pairs remaining significant after Bonferroni correction.

c

Remaining significant after Bonferroni correction.

Discussion

Rs908822 in SPRY1 (Yu et al. 2017) and rs8001641 as well as rs9545308 in SPRY2 (Ludwig et al. 2012; Yu et al. 2017) were previously identified to be associated with the risk of NSCL/P in different populations. In the current study, we used 1,908 NSCL/P trios to explore potential gene-gene interactions among SPRY genes. To note, SPRY3 was excluded due to its special location on the X chromosome. Although the single-SNP association analysis did not show any signal (data not shown), the gene-gene interaction analysis yielded 10 and 6 pairs of SNPs with significant interactions among European and Asian trios, respectively. The permutation tests further verified the significant findings.

SPRYs are sprouty receptor tyrosine kinase signaling antagonist genes that could play vital regulatory functions in biological processes (Hacohen et al. 1998; Gross et al. 2001; Impagnatiello et al. 2001). Yang et al. (2010) reported in their functional study that the conditional expression of SPRY1 in neural crest cells causes craniofacial defects in mice. The overexpression or deficiency of SPRY2 was reported to result in facial malformations and cleft palates in mice as well. SPRY2 may also act on the development of cleft palate via, or independent of, fibroblast growth factor (FGF) signaling pathways (Goodnough et al. 2007; Matsumura et al. 2011). Additionally, SPRY4 was reported to interact with IRF6 in periderm function in transgenic mice (Kousa et al. 2017). Moreover, the proteins encoded by SPRY genes act as crucial regulatory factors of FGF signaling pathways (Thisse and Thisse 2005). To note, previous studies identified several candidate genes for NSCL/P in FGF signaling pathways, such as FGF10, FGFR1, and FGF19 (Nikopensius et al. 2011; Wang et al. 2013; Yu et al. 2017). The biological evidence explained here indicated that SPRY genes potentially contribute to the development of NSCL/P.

Several studies identified pairwise gene-gene interactions contributing to the etiology of NSCL/P, such as PAX9-IRF6 (Song et al. 2013), MAFB-IRF6 (Xiao et al. 2017), and WNT-MAFB (Li et al. 2015). In our study, 1 pair of SNPs in SPRY genes was identified in 1,908 NSCL/P trios from different ancestries, which involved SPRY1 and SPRY2. In addition, in subgroup analyses, 7 pairs of SNPs involving SPRY1 and SPRY2 showed significant interactions among European and Asian subgroups, which enriched the evidence of the interaction between SPRY1 and SPRY2. Of these, 6 pairs of SNPs were revealed in European trios and 1 pair in Asian trios. Moreover, subgroup analyses revealed another 9 pairs of interactions between SPRY2 and SPRY4. Four pairs of SNPs in Europeans trios and 5 pairs of SNPs in Asians trios showed statistically significant interactions between SPRY2 and SPRY4. Despite none of these SNP-SNP interactions showing significance simultaneously in the overall analysis and subgroup analyses, multiple signals involving SPRY1-SPRY2 and SPRY2-SPRY4 altogether demonstrated that gene-gene interactions among SPRY genes potentially influence the risk of NSCL/P.

In the current study, several SNPs showed significant interactions with >1 SNP in another gene. For example, rs3860074 (SPRY1) simultaneously interacted with rs11149181, rs12854744, rs11618325, and rs1358977 in SPRY2, which might further provide evidence that genetic segments in SPRY1 and SPRY2 could interact with each other. A similar situation was also seen between SPRY2 and SPRY4. The SNPs involved in the gene-gene interactions in this study were mostly intron variants or located in intergenic regions. However, it was suggested that noncoding variants could regulate the expression of coding regions and play important roles in human traits and complex diseases (Zhang and Lupski 2015). In addition, 1 of the SNPs for gene-gene interaction, rs1358977 (SPRY2), belongs to noncoding transcript variants, which were recently considered functional genetic elements and risk factors of complex diseases (Kellis et al. 2014; Lai et al. 2015; Saghaeian Jazi et al. 2016). Thus, the noncoding SNPs identified by our interaction analysis may indirectly influence the transcription as well as the protein products. To note, proteins encoded by SPRY genes share a highly conserved ~110-residue cysteine-rich sequence in the C-terminal half, which is responsible for targeting the protein to cell membrane (Hacohen et al. 1998). The competition among SPRY proteins can be inferred according to the similarity of their binding domain membrane. If simultaneous variations of 2 SPRY genes led to abnormal affinity of their products to the membrane, the competitive inhibition could happen and then result in a nonadditive inhibitory effect of SPRY on downstream pathways, since the inhibitory effect differs among isoforms (Lao et al. 2006). SPRY2 protein was found to have a distinctly stronger inhibition effect on downstream pathways than other isoforms (Lao et al. 2006). This special character of SPRY2 might be a possible explanation about why only variants in SPRY2 showed interactions with SPRY1 and SPRY4 in this study, but none of variants in SPRY1 and SPRY4 showed interactions. Nevertheless, the biological mechanisms of how SPRY genes interacting with one another in the development of NSCL/P remain unclear. Further biological investigations are required to verify our findings.

Ludwig et al. (2012) conducted a meta-analysis of GWASs and reported a signal in SPRY2, rs8001641, located at chromosome 13:80118676. Jia et al. (2015) and Moreno Uribe et al. (2017) then replicated this signal among European populations yet failed to replicate it among Asian populations (Jia et al. 2015). Yu et al. (2017) reported rs9545308 in SPRY2 to be associated with NSCL/P among Chinese people, as well as a novel signal in SPRY1 (rs908822). These studies implied that SPRY genes potentially participated in the etiology of NSCL/P. However, the current study failed to replicate previous signals in SPRY genes (data not shown), which may have resulted from a limited sample size and an insufficient power.

Our study identified that gene-gene interactions among SPRY genes were associated with the risk of NSCL/P. This study enriched the evidence for the role of SPRY genes in NSCL/P and highlighted the importance of exploring gene-gene interactions in etiologic studies. Further studies are required to verify the findings of the current study, and the underlying mechanisms of these interactions need to be explored by more fundamental studies.

Author Contributions

R. Zhou, contributed to conception, design, data analysis, and interpretation, drafted and critically revised manuscript; M. Wang, contributed to conception and data analysis, critically revised the manuscript; W. Li, S. Wang, Z. Zhou, J. Li, contributed to data interpretation, critically revised the manuscript; T. Wu, T.H. Beaty, contributed to conception, design, and data acquisition, critically revised the manuscript; H. Zhu, contributed to conception, design, and data interpretation, critically revised manuscript. All authors gave final approval and agree to be accountable for all aspects of the work.

Supplemental Material

Supplemental_file – Supplemental material for Gene-Gene Interactions among SPRYs for Nonsyndromic Cleft Lip/Palate

Supplemental material, Supplemental_file for Gene-Gene Interactions among SPRYs for Nonsyndromic Cleft Lip/Palate by R. Zhou, M. Wang, W. Li, S. Wang, Z. Zhou, J. Li, T. Wu, H. Zhu and T.H. Beaty in Journal of Dental Research

Acknowledgments

We gratefully thank all the families at each recruitment site for participating this study and sincerely acknowledge the effort of the clinical, field, and laboratory staff who made this work possible and the Smile Train Foundation for supporting data collection in China.

Footnotes

A supplemental appendix to this article is available online.

The International Cleft Consortium for Genotyping and Analysis was funded by the National Institute for Dental and Craniofacial Research (U01-DE-018993) and the International Consortium to Identify Genes and Interactions Controlling Oral Clefts (2007 to 2009; principal investigator: T.H. Beaty). This study was also supported by the National Natural Science Foundation of China (81102178, 81573225, principal investigator: T. Wu), the Beijing Natural Science Foundation of China (7172115, principal investigator: T. Wu), and the Peking University Health Science Center Interdisciplinary Research Fund (BMU2017MX018, principal investigators: H. Zhu and T. Wu).

The authors declare no potential conflicts of interest with respect to the authorship and/or publication of this article.

References

  1. Beaty TH, Murray JC, Marazita ML, Munger RG, Ruczinski I, Hetmanski JB, Liang KY, Wu T, Murray T, Fallin MD, et al. 2010. A genome-wide association study of cleft lip with and without cleft palate identifies risk variants near MAFB and ABCA4. Nat Genet. 42(6):525–529. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Beaty TH, Taub MA, Scott AF, Murray JC, Marazita ML, Schwender H, Parker MM, Hetmanski JB, Balakrishnan P, Mansilla MA, et al. 2013. Confirming genes influencing risk to cleft lip with/without cleft palate in a case-parent trio study. Hum Genet. 132(7):771–781. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Birnbaum S, Ludwig KU, Reutter H, Herms S, Steffens M, Rubini M, Baluardo C, Ferrian M, Almeida de, Assis N, Alblas MA, et al. 2009. Key susceptibility locus for nonsyndromic cleft lip with or without cleft palate on chromosome 8q24. Nat Genet. 41(4):473–477. [DOI] [PubMed] [Google Scholar]
  4. Cordell HJ. 2002. Epistasis: what it means, what it doesn’t mean, and statistical methods to detect it in humans. Hum Mol Genet. 11(20):2463–2468. [DOI] [PubMed] [Google Scholar]
  5. de Araujo TK, Secolin R, Felix TM, de Souza LT, Fontes MI, Monlleo IL, de Souza J, Fett-Conte AC, Ribeiro EM, Xavier AC, et al. 2016. A multicentric association study between 39 genes and nonsyndromic cleft lip and palate in a brazilian population. J Craniomaxillofac Surg. 44(1):16–20. [DOI] [PubMed] [Google Scholar]
  6. Eichler EE, Flint J, Gibson G, Kong A, Leal SM, Moore JH, Nadeau JH. 2010. Missing heritability and strategies for finding the underlying causes of complex disease. Nat Rev Genet. 11(6):446–450. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Frazer KA, Murray SS, Schork NJ, Topol EJ. 2009. Human genetic variation and its contribution to complex traits. Nat Rev Genet. 10(4):241–251. [DOI] [PubMed] [Google Scholar]
  8. Goodnough LH, Brugmann SA, Hu D, Helms JA. 2007. Stage-dependent craniofacial defects resulting from sprouty2 overexpression. Dev Dyn. 236(7):1918–1928. [DOI] [PubMed] [Google Scholar]
  9. Gross I, Bassit B, Benezra M, Licht JD. 2001. Mammalian sprouty proteins inhibit cell growth and differentiation by preventing ras activation. J Biol Chem. 276(49):46460–46468. [DOI] [PubMed] [Google Scholar]
  10. Hacohen N, Kramer S, Sutherland D, Hiromi Y, Krasnow MA. 1998. Sprouty encodes a novel antagonist of FGF signaling that patterns apical branching of the Drosophila airways. Cell. 92(2):253–263. [DOI] [PubMed] [Google Scholar]
  11. Impagnatiello MA, Weitzer S, Gannon G, Compagni A, Cotten M, Christofori G. 2001. Mammalian sprouty-1 and -2 are membrane-anchored phosphoprotein inhibitors of growth factor signaling in endothelial cells. J Cell Biol. 152(5):1087–1098. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Jia Z, Leslie EJ, Cooper ME, Butali A, Standley J, Rigdon J, Suzuki S, Gongorjav A, Shonkhuuz TE, Natsume N, et al. 2015. Replication of 13q31.1 association in nonsyndromic cleft lip with cleft palate in europeans. Am J Med Genet A. 167(5):1054–1060. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Jugessur A, Lie RT, Wilcox AJ, Murray JC, Taylor JA, Saugstad OD, Vindenes HA, Abyholm F. 2003. Variants of developmental genes (TGFA, TGFB3, and MSX1) and their associations with orofacial clefts: a case-parent triad analysis. Genet Epidemiol. 24(3):230–239. [DOI] [PubMed] [Google Scholar]
  14. Kellis M, Wold B, Snyder MP, Bernstein BE, Kundaje A, Marinov GK, Ward LD, Birney E, Crawford GE, Dekker J, et al. 2014. Defining functional DNA elements in the human genome. Proc Natl Acad Sci U S A. 111(17):6131–6138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kousa YA, Roushangar R, Patel N, Walter A, Marangoni P, Krumlauf R, Klein OD, Schutte BC. 2017. IRF6 and SPRY4 signaling interact in periderm development. J Dent Res. 96(11):1306–1313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Lai Y, Xu P, Li Q, Ren D, Wang J, Xu K, Gao W. 2015. Downregulation of long noncoding RNA ZMAT1 transcript variant 2 predicts a poor prognosis in patients with gastric cancer. Int J Clin Exp Pathol. 8(5):5556–5562. [PMC free article] [PubMed] [Google Scholar]
  17. Lao DH, Chandramouli S, Yusoff P, Fong CW, Saw TY, Tai LP, Yu CY, Leong HF, Guy GR. 2006. A Src homology 3-binding sequence on the C terminus of Sprouty2 is necessary for inhibition of the Ras/ERK pathway downstream of fibroblast growth factor receptor stimulation. J Biol Chem. 281(40):29993–30000. [DOI] [PubMed] [Google Scholar]
  18. Leslie EJ, Carlson JC, Shaffer JR, Butali A, Buxo CJ, Castilla EE, Christensen K, Deleyiannis FW, Leigh FL, Hecht JT, et al. 2017. Genome-wide meta-analyses of nonsyndromic orofacial clefts identify novel associations between FOXE1 and all orofacial clefts, and TP63 and cleft lip with or without cleft palate. Hum Genet. 136(3):275–286. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Leslie EJ, Carlson JC, Shaffer JR, Buxo CJ, Castilla EE, Christensen K, Deleyiannis FWB, Field LL, Hecht JT, Moreno L, et al. 2017. Association studies of low-frequency coding variants in nonsyndromic cleft lip with or without cleft palate. Am J Med Genet A. 173(6):1531–1538. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Leslie EJ, Carlson JC, Shaffer JR, Feingold E, Wehby G, Laurie CA, Jain D, Laurie CC, Doheny KF, McHenry T, et al. 2016. A multi-ethnic genome-wide association study identifies novel loci for non-syndromic cleft lip with or without cleft palate on 2p24.2, 17q23 and 19q13. Hum Mol Genet. 25(13):2862–2872. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Leslie EJ, Liu H, Carlson JC, Shaffer JR, Feingold E, Wehby G, Laurie CA, Jain D, Laurie CC, Doheny KF, et al. 2016. A genome-wide association study of nonsyndromic cleft palate identifies an etiologic missense variant in GRHL3. Am J Hum Genet. 98(4):744–754. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Leslie EJ, Marazita ML. 2013. Genetics of cleft lip and cleft palate. Am J Med Genet C Semin Med Genet. 163C(4):246–258. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Li Q, Kim Y, Suktitipat B, Hetmanski JB, Marazita ML, Duggal P, Beaty TH, Bailey-Wilson JE. 2015. Gene-gene interaction among WNT genes for oral cleft in trios. Genet Epidemiol. 39(5):385–394. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Liu D, Wang H, Schwender H, Marazita ML, Wang Z, Yuan Y, Wang P, Liang KY, Wu-Chou YH, Wang M, et al. 2017. Gene-gene interaction of single nucleotide polymorphisms in 16p13.3 may contribute to the risk of non-syndromic cleft lip with or without cleft palate in chinese case-parent trios. Am J Med Genet A. 173(6):1489–1494. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Ludwig KU, Ahmed ST, Bohmer AC, Sangani NB, Varghese S, Klamt J, Schuenke H, Gultepe P, Hofmann A, Rubini M, et al. 2016. Meta-analysis reveals genome-wide significance at 15q13 for nonsyndromic clefting of both the lip and the palate, and functional analyses implicate GREM1 as a plausible causative gene. PLoS Genet. 12(3):e1005914. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Ludwig KU, Mangold E, Herms S, Nowak S, Reutter H, Paul A, Becker J, Herberz R, AlChawa T, Nasser E, et al. 2012. Genome-wide meta-analyses of nonsyndromic cleft lip with or without cleft palate identify six new risk loci. Nat Genet. 44(9):968–971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Mangold E, Ludwig KU, Birnbaum S, Baluardo C, Ferrian M, Herms S, Reutter H, de Assis NA, Chawa TA, Mattheisen M, et al. 2010. Genome-wide association study identifies two susceptibility loci for nonsyndromic cleft lip with or without cleft palate. Nat Genet. 42(1):24–26. [DOI] [PubMed] [Google Scholar]
  28. Matsumura K, Taketomi T, Yoshizaki K, Arai S, Sanui T, Yoshiga D, Yoshimura A, Nakamura S. 2011. Sprouty2 controls proliferation of palate mesenchymal cells via fibroblast growth factor signaling. Biochem Biophys Res Commun. 404(4):1076–1082. [DOI] [PubMed] [Google Scholar]
  29. Moreno Uribe LM, Fomina T, Munger RG, Romitti PA, Jenkins MM, Gjessing HK, Gjerdevik M, Christensen K, Wilcox AJ, Murray JC, et al. 2017. A population-based study of effects of genetic loci on orofacial clefts. J Dent Res. 96(11):1322–1329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Nikopensius T, Kempa I, Ambrozaityte L, Jagomagi T, Saag M, Matuleviciene A, Utkus A, Krjutskov K, Tammekivi V, Piekuse L, et al. 2011. Variation in FGF1, FOXE1, and TIMP2 genes is associated with nonsyndromic cleft lip with or without cleft palate. Birth Defects Res A Clin Mol Teratol. 91(4):218–225. [DOI] [PubMed] [Google Scholar]
  31. Panamonta V, Pradubwong S, Panamonta M, Chowchuen B. 2015. Global birth prevalence of orofacial clefts: a systematic review. J Med Assoc Thai. 98 Suppl 7:S11–S21. [PubMed] [Google Scholar]
  32. Saghaeian Jazi M, Samaei NM, Ghanei M, Shadmehr MB, Mowla SJ. 2016. Identification of new SOX2OT transcript variants highly expressed in human cancer cell lines and down regulated in stem cell differentiation. Mol Biol Rep. 43(2):65–72. [DOI] [PubMed] [Google Scholar]
  33. Song T, Wu D, Wang Y, Li H, Yin N, Zhao Z. 2013. SNPS and interaction analyses of IRF6, MSX1 and PAX9 genes in patients with nonsyndromic cleft lip with or without palate. Mol Med Rep. 8(4):1228–1234. [DOI] [PubMed] [Google Scholar]
  34. Steen KV. 2012. Travelling the world of gene-gene interactions. Brief Bioinform. 13(1):1–19. [DOI] [PubMed] [Google Scholar]
  35. Sun Y, Huang Y, Yin A, Pan Y, Wang Y, Wang C, Du Y, Wang M, Lan F, Hu Z, et al. 2015. Genome-wide association study identifies a new susceptibility locus for cleft lip with or without a cleft palate. Nat Commun. 6:6414. [DOI] [PubMed] [Google Scholar]
  36. Thisse B, Thisse C. 2005. Functions and regulations of fibroblast growth factor signaling during embryonic development. Dev Biol. 287(2):390–402. [DOI] [PubMed] [Google Scholar]
  37. Wang H, Zhang T, Wu T, Hetmanski JB, Ruczinski I, Schwender H, Liang KY, Murray T, Fallin MD, Redett RJ, et al. 2013. The FGF and FGFR gene family and risk of cleft lip with or without cleft palate. Cleft Palate Craniofac J. 50(1):96–103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Xiao Y, Taub MA, Ruczinski I, Begum F, Hetmanski JB, Schwender H, Leslie EJ, Koboldt DC, Murray JC, Marazita ML, et al. 2017. Evidence for SNP-SNP interaction identified through targeted sequencing of cleft case-parent trios. Genet Epidemiol. 41(3):244–250. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Yang X, Kilgallen S, Andreeva V, Spicer DB, Pinz I, Friesel R. 2010. Conditional expression of SPRY1 in neural crest causes craniofacial and cardiac defects. BMC Dev Biol. 10:48. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Yu Y, Zuo X, He M, Gao J, Fu Y, Qin C, Meng L, Wang W, Song Y, Cheng Y, et al. 2017. Genome-wide analyses of non-syndromic cleft lip with palate identify 14 novel loci and genetic heterogeneity. Nat Commun. 8:14364. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Zhang F, Lupski JR. 2015. Non-coding genetic variants in human disease. Hum Mol Genet. 24(R1):R102–R110. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplemental_file – Supplemental material for Gene-Gene Interactions among SPRYs for Nonsyndromic Cleft Lip/Palate

Supplemental material, Supplemental_file for Gene-Gene Interactions among SPRYs for Nonsyndromic Cleft Lip/Palate by R. Zhou, M. Wang, W. Li, S. Wang, Z. Zhou, J. Li, T. Wu, H. Zhu and T.H. Beaty in Journal of Dental Research


Articles from Journal of Dental Research are provided here courtesy of International and American Associations for Dental Research

RESOURCES